Moderna Stock Rose 6% Last Week. What’s Next?

Moderna Stock Rose 6% Last Week. What’s Next?

Moderna stock gained almost 6% over the last week (five trading days) outperforming the broader S&P 500 which was up about 2% over the same period. The recent gains come amid some upgrades on the stock by brokerage analysts and also by the U.S. FDA vaccines advisory committee’s unanimous vote in…